Carotid intima-media thickness in HIV-infected individuals: Relationship of premature atherosclerosis to neuropsychological deficits?

European Neurology

Volumn 55, Issue 3, 2006, Pages 166-171

  Yaldizli, Özgür ^a   Kastrup, Oliver ^a   Obermann, Mark ^a   Esser, Stefan ^a   Wilhelm, Hans ^a   Ley, Christian ^a   Diener, Hans Christoph ^a   Maschke, Matthias ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Atherosclerosis; HIV encephalopathy; Intima media thickness

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COGNITION; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; ENDOTHELIUM INJURY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLIC DISORDER; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; ATHEROSCLEROSIS; COGNITION DISORDERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TUNICA INTIMA; TUNICA MEDIA;

EID: 33745243708     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093576     Document Type: Article

References (19)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
2. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A: Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 2000;69:376-380.
3. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, Multicenter AIDS Cohort Study: HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001;56:257-260.
4. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA: Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-2099.
5. Holmberg SD, Moorman AC, Williamson JM, Tong TC, Ward DJ, Wood KC, Greenberg AE, Janssen RS, HIV Outpatient Study (HOPS) investigators: Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002;360:1747-1748.
6. Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, Sosman JM: Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001;104:257-262.
7. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-494.
8. Maggi P, Serio G, Epifani G, Fiorentino G, Saracino A, Fico C, Perilli F, Lillo A, Ferraro S, Gargiulo M, Chirianni A, Angarano G, Regina G, Pastore G: Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS 2000;14:F123-128.
9. Depairon M, Chessex S, Sudre P, Rodondi N, Doser N, Chave JP, Riesen W, Nicod P, Darioli R, Telenti A, Mooser V, Swiss HIV Cohort Study: Premature atherosclerosis in HIV-infected individuals - Focus on protease inhibitor therapy. AIDS 2001;15:329-334.
10. Seminari E, Pan A, Voltini G, Carnevale G, Maserati R, Minoli L, Meneghetti G, Tinelli C, Testa S: Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis 2002;162:433-438.
11. Mercie P, Thiebaut R, Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Morlat P, Ragnaud JM, Dupon M, Malvy D, Bellet H, Lawson-Ayayi S, Roudaut R, Dabis F: Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med 2002;34:55-63.
12. Chironi G, Escaut L, Gariepy J, Cogny A, Teicher E, Monsuez JJ, Levenson J, Simon A, Vittecoq D: Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients. J Acquir Immune Defic Syndr 2003;32:490-493.
13. Mercie P, Thiebaut R, Aurillac-Lavignolle V, Pellegrin JL, Yvorra-Vives M, Cipriano C, Neau D, Morlat P, Ragnaud J, Dupon M, Bonnet F, Lawson-Ayayi S, Malvy D, Roudaut R, Dabis F, on behalf of the Groupe d'Epidemiologie Clinique du Sida en Aquitaine (GECSA): Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med 2005;6:380-387.
14. Johnston SC, O'Meara ES, Manolio TA, Lefkowitz D, O'Leary DH, Goldstein S, Carlson MC, Fried LP, Longstreth WT Jr: Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 2004;140:237-247.
15. Zheng J, Gendelman HE: The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 1997;10:319-325.
16. Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H: Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 1999;100:832-837.
17. Talelli P, Ellul J, Terzis G, Lekka NP, Gioldasis G, Chrysanthopoulou A, Papapetropoulos T: Common carotid artery intima media thickness and post-stroke cognitive impairment. J Neurol Sci 2004;223:129-134.
18. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD: Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004;109:1603-1608.
19. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA: Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348:702-710.